Increasing the radioiodine dose does not improve cure rates in severe Graves’ hyperthyroidism : a clinical trial with historical control
Objective. It is generally accepted that higher doses of radioiodine (131I) improve cure rates in Graves’ disease (GD). In this trial we sought to evaluate whether very high 131I doses increase the efficacy of treatment in severe GD. Design. Clinical trial with historical control. Patients with GD a...
| Autor principal: | |
|---|---|
| Outros Autores: | , , , |
| Formato: | other article |
| Idioma: | eng |
| Publicado em: |
2015
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10183/111626 |
| País: | Brasil |
| Oai: | oai:www.lume.ufrgs.br:10183/111626 |